Chris McCurdy, Ph.D., director of the CTSI's Translational Drug Development Core, develops a key compound to be used in program designed to help end addiction long-term.
On April 10, 2023, The UF Clinical and Translational Science Institute, or CTSI, hosted its very first LHS Research Day, an event dedicated to showcasing the latest in Learning Health Systems, or LHS, research across the University of Florida and its Academic Health Center. This inaugural event was well-attended and left standing room only as attendees gathered to hear opening remarks from UF Health leaders, keynote presentations from visiting scholars.
Deadline to Submit Abstracts March 15, 2023 by 11:59PM EST…
Stephanie Staras, M..S.P.H., Ph.D., a researcher and University of Florida faculty member, aims to reduce HPV related cancer risk by addressing multiple barriers to vaccination in rural areas with the help of a $4 million, five-year National Institutes of Health grant that began in September 2022.
Join us to celebrate the research of MD-PhD students, and CTSI trainees, scholars and pilot awardees representing multiple departments and colleges across the University of Florida.
Researchers at University of Florida Health and the OneFlorida+ Clinical Research Network have begun recruiting patients to a national study to learn if several existing prescription and over-the-counter medications can help those with COVID-19 safely manage their symptoms at home and avoid hospitalization.
The new Translational Drug Development Core laboratory at the University of Florida provides services and expertise in bioanalysis, drug metabolism, and preclinical pharmacokinetics in order to help faculty and other partners move promising compounds from the lab into preclinical studies.
Updated Nov. 20, 2020 Written by Meghan Meyer A group of UF medical students who are also pursuing research doctoral degrees switched from training mode to execution mode with real-world impact recently when they published findings of a clinical trial. The five students in the…